These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24186700)

  • 61. Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.
    Korn S; Buhl R
    Respir Med; 2012 Jan; 106(1):57-67. PubMed ID: 21890335
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial.
    Woodcock A; Bleecker ER; Lötvall J; O'Byrne PM; Bateman ED; Medley H; Ellsworth A; Jacques L; Busse WW
    Chest; 2013 Oct; 144(4):1222-1229. PubMed ID: 23846316
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K; McQuire SE; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Device type and real-world effectiveness of asthma combination therapy: an observational study.
    Price D; Roche N; Christian Virchow J; Burden A; Ali M; Chisholm A; Lee AJ; Hillyer EV; von Ziegenweidt J
    Respir Med; 2011 Oct; 105(10):1457-66. PubMed ID: 21612903
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
    Lasserson TJ; Cates CJ; Ferrara G; Casali L
    Cochrane Database Syst Rev; 2008 Jul; (3):CD004106. PubMed ID: 18646100
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management.
    Roberts M; Mapel D; Petersen H; Blanchette C; Ramachandran S
    J Med Econ; 2011; 14(6):769-76. PubMed ID: 21942463
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 70. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.
    O'Connor RD; Rosenzweig JR; Stanford RH; Gilmore AS; Ryskina KL; Legorreta AP; Stempel DA
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):535-40. PubMed ID: 16400892
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges.
    Navaratnam P; Friedman HS; Urdaneta E
    Curr Med Res Opin; 2009 Dec; 25(12):2895-901. PubMed ID: 19821655
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medication adherence in patients with asthma using once-daily versus twice-daily ICS/LABAs.
    Averell CM; Stanford RH; Laliberté F; Wu JW; Germain G; Duh MS
    J Asthma; 2021 Jan; 58(1):102-111. PubMed ID: 31607180
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma.
    O'Connor RD; O'Donnell JC; Pinto LA; Wiener DJ; Legorreta AP
    Chest; 2002 Apr; 121(4):1028-35. PubMed ID: 11948029
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.
    Fabbri LM; Nicolini G; Olivieri D; Papi A
    Expert Opin Pharmacother; 2008 Feb; 9(3):479-90. PubMed ID: 18220498
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma.
    Scichilone N; Battaglia S; Sorino C; Paglino G; Martino L; Paternò A; Santagata R; Spatafora M; Nicolini G; Bellia V
    Allergy; 2010 Jul; 65(7):897-902. PubMed ID: 20121764
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
    Pharmacoeconomics; 1999; 16 Suppl 2():i-viii, 1-34. PubMed ID: 10724799
    [No Abstract]   [Full Text] [Related]  

  • 79. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis.
    Levy ML; Hardwell A; McKnight E; Holmes J
    Prim Care Respir J; 2013 Dec; 22(4):406-11. PubMed ID: 24042172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.